| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 2.25e-06 | 9 | 63 | 3 | GO:0160063 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 2.27e-06 | 9 | 64 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 9.73e-06 | 14 | 64 | 3 | GO:0072379 | |
| Domain | DUF2012 | 1.46e-07 | 4 | 63 | 3 | PF09430 | |
| Domain | DUF2012 | 1.46e-07 | 4 | 63 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 2.02e-06 | 8 | 63 | 3 | IPR013784 | |
| Domain | CarboxyPept_regulatory_dom | 1.02e-05 | 13 | 63 | 3 | IPR014766 | |
| Domain | - | 1.02e-05 | 13 | 63 | 3 | 2.60.40.1120 | |
| Domain | CarboxyPept-like_regulatory | 2.40e-05 | 17 | 63 | 3 | IPR008969 | |
| Domain | ConA-like_dom | 8.57e-04 | 219 | 63 | 5 | IPR013320 | |
| Domain | Gal-bind_lectin | 1.14e-03 | 15 | 63 | 2 | PF00337 | |
| Domain | Gal-bind_lectin | 1.14e-03 | 15 | 63 | 2 | SM00908 | |
| Domain | GALECTIN | 1.14e-03 | 15 | 63 | 2 | PS51304 | |
| Domain | Galectin_CRD | 1.14e-03 | 15 | 63 | 2 | IPR001079 | |
| Domain | GLECT | 1.14e-03 | 15 | 63 | 2 | SM00276 | |
| Domain | SPRY | 3.17e-03 | 87 | 63 | 3 | SM00449 | |
| Domain | SPRY | 3.94e-03 | 94 | 63 | 3 | PF00622 | |
| Domain | SPRY_dom | 3.94e-03 | 94 | 63 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 4.06e-03 | 95 | 63 | 3 | IPR001870 | |
| Domain | B302_SPRY | 4.06e-03 | 95 | 63 | 3 | PS50188 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 6.23e-09 | 3 | 65 | 3 | 25576386 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.49e-08 | 4 | 65 | 3 | 31833031 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 9267806 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 3.47e-07 | 8 | 65 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 5.19e-07 | 9 | 65 | 3 | 36261522 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TRPM7 CEP112 CEP95 SIPA1L1 PAK5 SEC24B SPIRE1 RAB11FIP1 PRAG1 PALLD FOXK1 | 5.32e-07 | 861 | 65 | 11 | 36931259 |
| Pubmed | DMXL2 PSMG2 MYO1E TRPM7 CLU NOMO2 SIPA1L1 ZBTB5 DLG4 MTMR10 MTUS2 CUX1 WDR47 | 6.19e-07 | 1285 | 65 | 13 | 35914814 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.02e-06 | 11 | 65 | 3 | 32820719 | |
| Pubmed | The lurcher gene induces apoptotic death in cerebellar Purkinje cells. | 3.44e-06 | 2 | 65 | 2 | 7743930 | |
| Pubmed | Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. | 3.44e-06 | 2 | 65 | 2 | 11502259 | |
| Pubmed | S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. | 3.44e-06 | 2 | 65 | 2 | 21745643 | |
| Pubmed | Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. | 3.44e-06 | 2 | 65 | 2 | 19556522 | |
| Pubmed | 7.79e-06 | 67 | 65 | 4 | 16806233 | ||
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 1.13e-05 | 156 | 65 | 5 | 30409884 | |
| Pubmed | 1.66e-05 | 1006 | 65 | 10 | 15226823 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 22117215 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 2.70e-05 | 31 | 65 | 3 | 19136429 | |
| Pubmed | 3.27e-05 | 33 | 65 | 3 | 30783098 | ||
| Pubmed | Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. | 3.91e-05 | 35 | 65 | 3 | 37758766 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 4.50e-05 | 208 | 65 | 5 | 33230847 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.53e-05 | 344 | 65 | 6 | 30333137 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 4.76e-05 | 910 | 65 | 9 | 36736316 | |
| Pubmed | Role of Unc51.1 and its binding partners in CNS axon outgrowth. | 5.13e-05 | 6 | 65 | 2 | 15014045 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 28973854 | ||
| Pubmed | 5.53e-05 | 110 | 65 | 4 | 27889896 | ||
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 7.18e-05 | 7 | 65 | 2 | 15207857 | |
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 32320668 | ||
| Pubmed | 7.34e-05 | 963 | 65 | 9 | 28671696 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 8.00e-05 | 974 | 65 | 9 | 28675297 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 37261953 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 19497882 | ||
| Pubmed | 1.40e-04 | 608 | 65 | 7 | 16713569 | ||
| Pubmed | 1.47e-04 | 613 | 65 | 7 | 22268729 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.52e-04 | 55 | 65 | 3 | 19468303 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 25232112 | ||
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 36030255 | ||
| Pubmed | Ndfip1 is required for the development of pyramidal neuron dendrites and spines in the neocortex. | 1.87e-04 | 11 | 65 | 2 | 23897647 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 12586822 | ||
| Pubmed | 1.88e-04 | 282 | 65 | 5 | 23667531 | ||
| Pubmed | 2.10e-04 | 650 | 65 | 7 | 38777146 | ||
| Pubmed | 2.28e-04 | 63 | 65 | 3 | 31266804 | ||
| Pubmed | 2.28e-04 | 63 | 65 | 3 | 25680957 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.52e-04 | 670 | 65 | 7 | 22990118 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 31841517 | ||
| Pubmed | DMXL2 MYO1E CLU SIPA1L1 SPIRE1 PSMD3 DLG4 NDUFB4 MTUS2 WDR47 | 3.07e-04 | 1431 | 65 | 10 | 37142655 | |
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 19240213 | ||
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 33305180 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 3.08e-04 | 14 | 65 | 2 | 17389516 | |
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 19703589 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 26263173 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 31515109 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 4.08e-04 | 516 | 65 | 6 | 36610398 | |
| Pubmed | PPP2R5C SIPA1L1 SEC24B GON4L SPIRE1 RAB11FIP1 NDUFB4 FOXK1 MAN1B1 NOMO1 | 4.38e-04 | 1497 | 65 | 10 | 31527615 | |
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 27476503 | ||
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 15603741 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 5.76e-04 | 19 | 65 | 2 | 22144910 | |
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 6.52e-04 | 90 | 65 | 3 | 15616553 | |
| Pubmed | 6.57e-04 | 371 | 65 | 5 | 15747579 | ||
| Pubmed | 6.75e-04 | 568 | 65 | 6 | 37774976 | ||
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 6.95e-04 | 92 | 65 | 3 | 10493829 | |
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 31577955 | ||
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 36343267 | ||
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 22479202 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.54e-04 | 218 | 65 | 4 | 33378226 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PPP2R5C MYO1E SIPA1L1 SEC24B SPIRE1 RAB11FIP1 SMC2 FOXK1 NOMO1 | 7.55e-04 | 1321 | 65 | 9 | 27173435 |
| Pubmed | 7.70e-04 | 808 | 65 | 7 | 20412781 | ||
| Pubmed | 8.04e-04 | 814 | 65 | 7 | 23251661 | ||
| Pubmed | 8.48e-04 | 225 | 65 | 4 | 12168954 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 9.00e-04 | 398 | 65 | 5 | 35016035 | |
| Pubmed | 9.09e-04 | 1084 | 65 | 8 | 11544199 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 9.35e-04 | 231 | 65 | 4 | 16452087 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 9.37e-04 | 102 | 65 | 3 | 15778465 | |
| Pubmed | 9.94e-04 | 407 | 65 | 5 | 12693553 | ||
| Pubmed | 1.00e-03 | 25 | 65 | 2 | 28288114 | ||
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.00e-03 | 25 | 65 | 2 | 2283726 | |
| Pubmed | 1.09e-03 | 26 | 65 | 2 | 8218172 | ||
| Pubmed | Onecut1 and Onecut2 play critical roles in the development of the mouse retina. | 1.17e-03 | 27 | 65 | 2 | 25313862 | |
| Pubmed | 1.25e-03 | 1139 | 65 | 8 | 36417873 | ||
| Pubmed | 1.26e-03 | 28 | 65 | 2 | 12471243 | ||
| Pubmed | Full function of exon junction complex factor, Rbm8a, is critical for interneuron development. | 1.26e-03 | 28 | 65 | 2 | 33154347 | |
| Pubmed | 1.26e-03 | 28 | 65 | 2 | 23006423 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 1.26e-03 | 28 | 65 | 2 | 31600191 | |
| Pubmed | 1.27e-03 | 251 | 65 | 4 | 29031500 | ||
| Pubmed | 1.31e-03 | 1429 | 65 | 9 | 35140242 | ||
| Pubmed | 1.36e-03 | 437 | 65 | 5 | 20562859 | ||
| Pubmed | 1.38e-03 | 653 | 65 | 6 | 33742100 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.51e-03 | 908 | 65 | 7 | 19274049 | |
| Pubmed | 1.61e-03 | 268 | 65 | 4 | 33640491 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.68e-03 | 125 | 65 | 3 | 32891193 | |
| Pubmed | Regulation of prefrontal patterning and connectivity by retinoic acid. | 1.86e-03 | 34 | 65 | 2 | 34599305 | |
| Interaction | YWHAH interactions | MYO1E TRPM7 CEP112 CEP95 SIPA1L1 PAK5 SEC24B SPIRE1 RAB11FIP1 ATXN1L PRAG1 MTMR10 PALLD FOXK1 | 4.86e-06 | 1102 | 62 | 14 | int:YWHAH |
| Interaction | YWHAE interactions | PPP2R5C TRPM7 CEP112 CEP95 SIPA1L1 PAK5 ASNS SPIRE1 PSMD3 DLG4 RAB11FIP1 SMC2 PRAG1 FOXK1 | 2.14e-05 | 1256 | 62 | 14 | int:YWHAE |
| Cytoband | 16q22.2 | 4.48e-04 | 22 | 65 | 2 | 16q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 9.92e-04 | 137 | 65 | 3 | chr9q31 | |
| Cytoband | 9q31.1 | 1.56e-03 | 41 | 65 | 2 | 9q31.1 | |
| Cytoband | 18p11.21 | 2.31e-03 | 50 | 65 | 2 | 18p11.21 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.69e-04 | 15 | 43 | 2 | 529 | |
| GeneFamily | Galectins | 5.69e-04 | 15 | 43 | 2 | 629 | |
| GeneFamily | Forkhead boxes | 4.69e-03 | 43 | 43 | 2 | 508 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 4.22e-06 | 98 | 64 | 5 | MM942 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 7.99e-06 | 297 | 64 | 7 | MM1003 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ABCA1 CLU CEP112 SEC24B GON4L RAB11FIP1 CPT1A PALLD CUX1 WDR47 | 2.85e-05 | 822 | 64 | 10 | M6782 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 155 | 64 | 5 | 29c4e9947bb4f7e257ed5c3bcf21bd67f88d473f | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 8.14e-06 | 191 | 64 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.23e-06 | 196 | 64 | 5 | bd2c2de103e28b65ea537c22f71225cb0deef1e0 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 9.23e-06 | 196 | 64 | 5 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.23e-06 | 196 | 64 | 5 | 072a4150ae521c6589b0f7cd60e975fb33715bf4 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 9.69e-06 | 198 | 64 | 5 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.97e-05 | 153 | 64 | 4 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 165 | 64 | 4 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 165 | 64 | 4 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 170 | 64 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 176 | 64 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 177 | 64 | 4 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-04 | 178 | 64 | 4 | a28683690ab8a60eb18f3ef87ea85da4e95b22df | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 178 | 64 | 4 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 1.28e-04 | 179 | 64 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 182 | 64 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 183 | 64 | 4 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 183 | 64 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.42e-04 | 184 | 64 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 185 | 64 | 4 | 5ed49b6d8214c6119355a6d3ee4e25d40bcc0c53 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.45e-04 | 185 | 64 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.48e-04 | 186 | 64 | 4 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 186 | 64 | 4 | b3358e0fa6d845c81e94d56c8575f016621d28ff | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 186 | 64 | 4 | 15f2e5905486e33f6f7b3b3e9758a0559e8c61ee | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-04 | 186 | 64 | 4 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 1.51e-04 | 187 | 64 | 4 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-04 | 188 | 64 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 188 | 64 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 188 | 64 | 4 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-04 | 189 | 64 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.57e-04 | 189 | 64 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.57e-04 | 189 | 64 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 64 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 64 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.61e-04 | 190 | 64 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.61e-04 | 190 | 64 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.64e-04 | 191 | 64 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 191 | 64 | 4 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 191 | 64 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 191 | 64 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 191 | 64 | 4 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 191 | 64 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.67e-04 | 192 | 64 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.67e-04 | 192 | 64 | 4 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 193 | 64 | 4 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 1.71e-04 | 193 | 64 | 4 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.71e-04 | 193 | 64 | 4 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 64 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.77e-04 | 195 | 64 | 4 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 1.77e-04 | 195 | 64 | 4 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-04 | 196 | 64 | 4 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.81e-04 | 196 | 64 | 4 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.81e-04 | 196 | 64 | 4 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 197 | 64 | 4 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.84e-04 | 197 | 64 | 4 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.84e-04 | 197 | 64 | 4 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.84e-04 | 197 | 64 | 4 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.84e-04 | 197 | 64 | 4 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-04 | 197 | 64 | 4 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.84e-04 | 197 | 64 | 4 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 1.84e-04 | 197 | 64 | 4 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.88e-04 | 198 | 64 | 4 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | 3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 1.88e-04 | 198 | 64 | 4 | 807e3ed34739eca159dd0970f884b073e588c649 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 199 | 64 | 4 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 1.95e-04 | 200 | 64 | 4 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Sigmoid-(7)_Mast_cell-(70)_Mast|Sigmoid / shred on region, Cell_type, and subtype | 1.95e-04 | 200 | 64 | 4 | 7224ee639d56509de854203653a85ab09e6f05fe | |
| ToppCell | Sigmoid-Mast_cell|Sigmoid / Region, Cell class and subclass | 1.95e-04 | 200 | 64 | 4 | 025125d8b9c6540d9cdeea7f0fe9c58aec2a16b0 | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 200 | 64 | 4 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | Sigmoid-(7)_Mast_cell|Sigmoid / shred on region, Cell_type, and subtype | 1.95e-04 | 200 | 64 | 4 | bd8e0f027055bb34e99aa0e271ec3a0912f666bb | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 1.95e-04 | 200 | 64 | 4 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 1.95e-04 | 200 | 64 | 4 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Sigmoid-Mast_cell-Mast|Sigmoid / Region, Cell class and subclass | 1.95e-04 | 200 | 64 | 4 | e7e49e192a86566ed96f1e54657dd2ebc9036d47 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 200 | 64 | 4 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 1.95e-04 | 200 | 64 | 4 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 200 | 64 | 4 | a3f22826f3d8f917ff0594bdadd93b60763bcaa2 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-04 | 200 | 64 | 4 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| Disease | coronary artery calcification | 3.52e-05 | 450 | 60 | 7 | EFO_0004723 | |
| Disease | heart rate | 1.15e-03 | 225 | 60 | 4 | EFO_0004326 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.49e-03 | 28 | 60 | 2 | DOID:8466 (biomarker_via_orthology) | |
| Disease | glycoprotein measurement | 1.85e-03 | 119 | 60 | 3 | EFO_0004555 | |
| Disease | acne | 2.13e-03 | 125 | 60 | 3 | EFO_0003894 | |
| Disease | Intellectual Disability | 2.15e-03 | 447 | 60 | 5 | C3714756 | |
| Disease | Spinocerebellar Ataxia Type 2 | 2.19e-03 | 34 | 60 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 2.19e-03 | 34 | 60 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 2.19e-03 | 34 | 60 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 2.19e-03 | 34 | 60 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 2.19e-03 | 34 | 60 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 2.19e-03 | 34 | 60 | 2 | C0087012 | |
| Disease | docosahexaenoic acid measurement | 2.23e-03 | 127 | 60 | 3 | EFO_0007761 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSYYLSLPPEMRIPK | 426 | P08243 | |
| AFFPLPLTPTLYKMH | 191 | Q9NP73 | |
| MPTVSSYPPLAISLK | 751 | P39880 | |
| PLMYPASFVFKIPST | 1751 | O95477 | |
| RPEPGTLKILPSYMS | 86 | Q8N8E3 | |
| KPMLYSFQTSLPRLP | 161 | P50416 | |
| IYEMRPLSPPSLSLS | 96 | Q12887 | |
| ILPIMFPSLYRNSKT | 366 | Q13362 | |
| TYSRLSVPMPLPTVL | 476 | Q8TDJ6 | |
| PPTFYRSAMLLKPQL | 756 | Q5JR59 | |
| TPSSKELLFYPPSME | 766 | P69849 | |
| IPLRMSSYTFKRPVT | 26 | Q8WWY6 | |
| YTYPRLSEPTMCIPK | 316 | Q9P286 | |
| TPSSKELLFYPPSME | 766 | Q5JPE7 | |
| MSFLTVPYKLPVSLS | 1 | A8MUM7 | |
| MFSLKPPKPTFRSYL | 1 | Q9NXD2 | |
| MLYKVAVPPATFSPT | 81 | P0C7T5 | |
| ISTPSPESLRYALMP | 461 | Q86X51 | |
| RSPIKTMSSIPYQPT | 976 | O43424 | |
| TPSSKELLFYPPSME | 766 | Q15155 | |
| QPAKPPSSYIALITM | 101 | Q12950 | |
| MSFPKYKPSSLRTLP | 1 | O95168 | |
| RLMPAFRTPSKIPYS | 361 | Q9UKM7 | |
| KPAMSPLLTRPSYIR | 121 | Q8WX93 | |
| MSSLPVPYKLPVSLS | 1 | Q9UHV8 | |
| SIVSYPVKRPPLTMT | 2616 | Q4G0P3 | |
| MLPSLAPSKFRKPYV | 1101 | Q3T8J9 | |
| RPSSLVAKPVAYMPA | 486 | P85037 | |
| MLYPPSVLSKSRTSF | 221 | Q96GE4 | |
| MTPTSPRRYSPVAKD | 286 | P78352 | |
| PKFVSTTLRPTLMPY | 126 | Q8IY82 | |
| IIYPTAPPRSYTPMK | 56 | Q5VWZ2 | |
| MAPSSLKLFPLYVLA | 1066 | O95487 | |
| YKPAPMDLSFIKLTP | 976 | Q92736 | |
| PMKFPPTYSLASPTL | 131 | Q8N813 | |
| ISMYLQPPSPSSKDR | 256 | Q9GZK3 | |
| MLVIPSTFLTKRLPY | 156 | Q8NH53 | |
| PPNSFYMVRIISKAP | 646 | Q5T011 | |
| KSMTLPSYRPAPLVS | 391 | Q6WKZ4 | |
| LFTTSPLMLQYIPKP | 391 | P0CI25 | |
| SLMLKSLTYPERPPL | 421 | Q6XZB0 | |
| STPSIPPEMLASYKS | 566 | P0DPF3 | |
| SRFLMPEAYPSSPRK | 151 | O43166 | |
| LYESSDLPLMKLPPS | 791 | O75626 | |
| PAPLYSPTSQKIMTK | 886 | P63128 | |
| PKSRIVRSLMPFSPY | 221 | P10909 | |
| PLISKLSPYPSSPMR | 286 | O94967 | |
| KHYLTTRTLPMSPPS | 116 | O15062 | |
| PSLKRSLMPYFLLTQ | 351 | O43242 | |
| MRLPSKPYSTLPIFS | 626 | Q08AE8 | |
| LFTTSPLMLQYIPKP | 391 | P0CI26 | |
| ASAPVMLRVLYPPKT | 1521 | Q9BZZ2 | |
| SSPYSKPTIAVKPTM | 76 | Q86YV5 | |
| SLILSMLLFKPAPIY | 1096 | O95347 | |
| KLMTPLSRSAPTTLY | 286 | Q6ZNC4 | |
| SLMPSIPRETSPYLA | 231 | Q8IYT8 | |
| SPPSLTMPAEAKTYR | 1356 | Q96JM2 | |
| RTSPPTPAMYKFRPA | 346 | Q9ULC8 | |
| STPFRYLLTPSMQKS | 136 | Q969U7 | |
| SLLPVAYTIMSLPPS | 706 | Q8TDI7 | |
| LSASRYPTISMVKPL | 411 | O96006 | |
| LPKVMIPLSSIPTYN | 296 | Q9H4I2 | |
| MKPKSIPYSPRFLEV | 1691 | Q96QT4 | |
| SKPVSPSLDPLAMLY | 761 | Q6ZSZ6 | |
| RPPTQMEAKSPFYLT | 641 | Q8N8K9 | |
| KSLYTSMARPPLPRQ | 986 | Q12965 |